Suzhou Youyi Biotechnology develops serum-free culture media for biopharmaceutical production, research, and diagnostics.
Founded in 2022 and based in Suzhou, China, Suzhou Youyi Biotechnology develops dry powder and liquid serum-free culture media, including products for stable expression, cell and gene therapy, research, diagnostics, and vaccines. Its products serve biopharmaceutical production, medical aesthetics, and scientific research. In June 2026, it closed a Series A round co-led by Tenykin Capital and Nano-Micro, with Wujiang Dongyun Venture Capital participating. The funds are intended for R&D platform development and domestic and international sales channels.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in